Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growth (ABBV:NYSE) - Seeking Alpha
Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growth (ABBV:NYSE) Seeking Alpha
重要性:RSS 导入条目,等待编辑或代理补充市场影响解读。
Constellation targets $12.50-$12.80 full-year 2026 adjusted operating EPS as it outlines $4.3B nuclear uprate plan - Seeking Alpha
Constellation targets $12.50-$12.80 full-year 2026 adjusted operating EPS as it outlines $4.3B nuclear uprate plan Seeking Alpha
重要性:RSS 导入条目,等待编辑或代理补充市场影响解读。
Earnings Scoreboard: 86% of reporting firms beat EPS estimates, 78% post Y/Y earnings growth - Seeking Alpha
Earnings Scoreboard: 86% of reporting firms beat EPS estimates, 78% post Y/Y earnings growth Seeking Alpha
重要性:RSS 导入条目,等待编辑或代理补充市场影响解读。
Earnings Scoreboard: 83% of reporting firms beat EPS estimates, 79% post Y/Y earnings growth - Seeking Alpha
Earnings Scoreboard: 83% of reporting firms beat EPS estimates, 79% post Y/Y earnings growth Seeking Alpha
重要性:RSS 导入条目,等待编辑或代理补充市场影响解读。
Seven of eight consumer staples companies beat EPS estimates in Q3 2026 earnings week: Earnings scorecard - Seeking Alpha
Seven of eight consumer staples companies beat EPS estimates in Q3 2026 earnings week: Earnings scorecard Seeking Alpha
重要性:RSS 导入条目,等待编辑或代理补充市场影响解读。
Countdown to American International Group (AIG) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS - Zacks Investment Research
Countdown to American International Group (AIG) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS Zacks Investment Research
重要性:RSS 导入条目,等待编辑或代理补充市场影响解读。
$WMT Is Overvalued
We all know the rotation trade has been on and off all throughout the year and it started again in October. Consumer defensives are now reaching biblical valuations across the board. WMT is priced at 47x earnings (33% above the 5 year average) and the company has a YoY growth rate of 5.3%, compared to other sectors in this market, this is through the ceiling valuations. WMT has dropped on all 3 earnings this year, 1.38% Feb, 7.27% in May and 9.5% in Aug, despite beating EPS on all 3 instances. Earnings call is Thursday before the open, if they do not show an insane beat on growth rate it only makes sense to correct. Technicals: there was a large gap in June that has recently been filled. Currently 9% above 200 daily MA. Positions 25x Dec 18 $130P 25x Dec 4 $125P opening Monday Price Target: $116   submitted by   /u/neillson01 [link]   [comments]
重要性:RSS 导入条目,等待编辑或代理补充市场影响解读。
$MU at 3.6x forward earnings is not cheap. It is the top.
Every cycle, semiconductors look cheapest right before they break. The P/E collapses because peak earnings are about to disappear, not because the stock got cheap. The denominator is the trap. The SOX is down 38.5 percent from its June peak while forward EPS estimates for the index have risen 155 percent this year. The forward P/E "fell" to 13.0x, the lowest since January 2019. The index did not get cheaper. The estimates exploded. $MU trades at 3.6x forward earnings. It printed a 3.40x trailing multiple at the October 2018 top too, right before earnings went to losses. $MU gross margin just hit 75 percent, the highest in company history, on a commodity product. In fiscal 2023 that margin was negative 9.1 percent. $AVGO trades at 15.1x forward earnings on 85.5 percent estimated revenue growth. $ALAB trades at 26.8x on 153.7 percent growth. Those multiples only work if peak growth is mid-cycle. It is not. Bank of America estimates a 20 percent cut to 2027 AI capital spending cuts indust
重要性:RSS 导入条目,等待编辑或代理补充市场影响解读。
A little patience paid off (DNUT gains porn)
Krispy Kreme had a blow out Q3, beating on revenue/EPS and raising revenue guidance. I trimmed most of my shares and sold calls against the rest to realize most of the gains from this pop. Might trade back in once it fades more of Thursday's move. Letting my long calls ride as lottos.   submitted by   /u/SurpriseInTheShower [link]   [comments]
重要性:RSS 导入条目,等待编辑或代理补充市场影响解读。
$10,000,000 RDDT YOLO Post-Mortem: I Was Wrong :(
For some reason, the Reddit automated filters removed my other attempt at this post... I guess that's the icing on the cake to the loss.... Hoping this post actually sticks... Well, fuck. Yesterday, I posted my $10 million RDDT YOLO ahead of earnings. I said you degenerates would either get to watch me make a fortune or enjoy some premium loss porn. Congratulations. You got the loss porn. And holy shit, did I deliver. Roughly $5 million gone in one earnings report. If there's *any* positive, it's that a lot of the holdings are shares vs being fully options. But again, that's a *super minor* positive. As for the total gain loss column not being shown on the main RDDT shares and some of the $200 short puts, it's because Fidelity has this fucking annoying thing where if the position changes that day before market opens, then the total G&L doesn't update until the next day. You can still see the values and the today G&L though. First things first: I was wrong To everyone who warned
重要性:RSS 导入条目,等待编辑或代理补充市场影响解读。
$10,000,000 dollar RDDT YOLO - prepped for earnings after market close!
This is the largest YOLO play I've ever made. Figured you degenerates would enjoy seeing it deep in the red, and potentially get to cheer as it gets even worse after earnings tonight. Or, if RDDT pops, you can give me the big "fuck you"! I've posted plenty of DD on RDDT over the past several months, but here's the short version: Revenue growth: 61% YoY, with 91% gross margins. EPS growth: 178% YoY, with substantial operating leverage. Advertiser growth: 70%+ YoY, driving 40% higher ad prices. User growth: 18% global DAU growth, despite everyone obsessing over 1% U.S. logged-in DAU growth. Reddit Max: AI-powered ad optimization is making existing ad inventory more valuable. Valuation: Around 21x estimated 2026 earnings, despite analysts projecting roughly 30%+ annual growth over the next several years (and analysts have been *dramatically* under estimating Reddit's growth since its IPO). Balance sheet: Approximately $2.8B in cash, essentially no debt. Meanwhile, the stock is down over 5
重要性:RSS 导入条目,等待编辑或代理补充市场影响解读。
Bausch Health Companies Inc - Q3 Earnings $BHC
Bausch Health Companies develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. BHC just reported Q3 earnings and significantly beat estimates. Q3 Earnings: EPS - $1.77 vs Est $1.26 (39.7% beat) Rev - $2.94B vs Est $2.75B (7% beat) Operating Income - $983m Operating cashflow - 581M Net Income - $436M Repaid 650M of debt reducing annual interest costs of $55m Authorized $50m of share repurchase Raised guidance for Q4. BHC has beat earnings in Q1, Q2 and now Q3 of 2026. Q2 Earnings price movement: On the Q2 earnings beat the stock ran from $4.4 to $7.35 in 2 days after ER release and opening flat. I expect a similar movement for this Q3 earnings release as the EPS and Revenue beat were both bigger then Q2. Why I am long: BHC has consistently beat earnings in 2026, actively
重要性:RSS 导入条目,等待编辑或代理补充市场影响解读。
IDACORP Q3 Earnings & Revenues Outpace Estimates, '26 EPS View Raised - Zacks Investment Research
IDACORP Q3 Earnings & Revenues Outpace Estimates, '26 EPS View Raised Zacks Investment Research
重要性:RSS 导入条目,等待编辑或代理补充市场影响解读。
Sandisk sees revenue nearly quintuple — and a stock split is on the way
https://www.marketwatch.com/story/sandisk-sees-revenue-nearly-quintuple-and-its-stock-is-heading-higher-b9318916?mod=goog\_fin\_scmw Sandisk down 3.84% as of aftermarket close. - Announced 8 to 1 stock split, effective Nov. 19 - Revenue 11B vs. 10.7B - Forecast 12.2-12.6B for next quarter, vs 12.3B expected - Adjusted quarterly gross margin at 85.1% - Adjusted EPS at $52.6 vs $46.67 expected CEO David Goeckeler called out "robust and growing demand for our products," which fueled "outpaced growth in our data-center business."   submitted by   /u/anotherloserhere [link]   [comments]
重要性:RSS 导入条目,等待编辑或代理补充市场影响解读。